Ototoxicity risk assessment combining distortion product otoacoustic emissions with a cisplatin dose model (original) (raw)
Detection of cisplatin-induced ototoxicity with transient evoked otoacoustic emission test before pure tone audiometer
Suleyman Yilmaz, Emin Karaman
European Archives of Oto Rhino Laryngology and Head Neck, 2010
View PDFchevron_right
Ototoxicity as a Side-Effect of Drugs: Literature Review
Magdalena B . Skarzynska
Journal of hearing science, 2020
View PDFchevron_right
The use of high-frequency audiometry increases the diagnosis of asymptomatic hearing loss in pediatric patients treated with cisplatin-based chemotherapy
Marino Patricia
Pediatric Blood & Cancer, 2012
View PDFchevron_right
Effect of cisplatin on distortion product otoacoustic emissions in Japanese patients
Juichi Ito
The Laryngoscope, 2012
View PDFchevron_right
Protective effect of thymoquinone against cisplatin-induced ototoxicity
Mehmet Somdas
European Archives of Oto-Rhino-Laryngology, 2012
View PDFchevron_right
GSTM1 null and GSTT1 null: predictors of cisplatin-caused acute ototoxicity measured by DPOAEs
Barna Budai
Journal of Molecular Medicine
View PDFchevron_right
Perspectives and practices of ototoxicity monitoring
Jessica Paken
South African Journal of Communication Disorders
View PDFchevron_right
Distortion-product otoacoustic emissions and auditory brainstem responses sensitivity assessment in cisplatin-induced ototoxicity in rats Summary
José Valdir , dos Reis Ramos
2009
View PDFchevron_right
Monitoring Ototoxicity through Otoacoustic Emissions. Present, COVID-19, and Future Related Insights
Georgios Panagiotopoulos
2020
View PDFchevron_right
Group-Wide, Prospective Study of Ototoxicity Assessment in Children Receiving Cisplatin Chemotherapy (ACCL05C1): A Report From the Children's Oncology Group
Ha Tuyen Dang
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2016
View PDFchevron_right
Cisplatin Ototoxicity in the Sprague Dawley Rat Evaluated by Distortion Product Otoacoustic Emissions:Ototoxicidad por Cisplatino en la rata Sprague Dawley evaluada mediante productos de distorsión de las emisiones otoacústicas
Stavros Hatzopoulos
International Journal of Audiology, 2001
View PDFchevron_right
Ototoxicity of cisplatin plus standard radiation therapy vs. accelerated radiation therapy in glioblastoma patients
Kurt Jaeckle
Journal of Neuro-Oncology, 2005
View PDFchevron_right
Recommendations for ototoxicity surveillance for childhood, adolescent, and young adult cancer survivors: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group in collaboration with the PanCare Consortium
Beth Brooks
The Lancet Oncology, 2019
View PDFchevron_right
Objective Measures of Ototoxicity
Kathleen Dunckley
Perspectives on Hearing and Hearing Disorders Research and Diagnostics, 2005
View PDFchevron_right
Research protocol: Cisplatin-associated ototoxicity amongst patients receiving cancer chemotherapy and the feasibility of an audiological monitoring program
Jessica Paken
BMC Women's Health, 2017
View PDFchevron_right
Ototoxicity of Ototopical Drops—An Update
Michael Andre T. Hawke
Otolaryngologic Clinics of North America, 2007
View PDFchevron_right
Cisplatin ototoxicity in the Sprague Dawley rat evaluated by distortion product otoacoustic emissions
Kathleen Campbell, andrea albertin, Stavros Hatzopoulos
Audiology : official organ of the International Society of Audiology
View PDFchevron_right
Chronotolerance for cisplatin ototoxicity in the rat
Ryan Harrison
Hearing Research, 2018
View PDFchevron_right
Effects of sevoflurane and desflurane on otoacoustic emissions in humans
Ahmet Atas
European Archives of Oto-Rhino-Laryngology, 2014
View PDFchevron_right
A new grading system for ototoxicity in adults
Fons Balm
The Annals of otology, rhinology, and laryngology, 2014
View PDFchevron_right